当前位置: 首页 > 详情页

Colivelin Rescues Ischemic Neuron and Axons Involving JAK/STAT3 Signaling Pathway

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [a]Shanxi Medical University, Taiyuan, China [b]China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [c]Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China [d]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China [e]Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China [f]Center for Neurological Diseases, The Third People’s Hospital of Datong, Shanxi, China
出处:
ISSN:

关键词: axonal remodeling colivelin ischemic stroke JAK/STAT3 neuronal death

摘要:
Colivelin is a neuroprotective humanin family peptide with potent long-term capacity against Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease. We seek to investigate whether this effect of Colivelin also govern ischemic brain injury, and potential mechanism underlying the Colivelin-mediated action on ischemic neurons. We adopted 60 min induction of transient focal cerebral ischemia and reperfusion in mice. We found that relative to mice receiving vehicle, Colivelin administration decreased the neurological deficits and infarct lesion induced by brain ischemia. Colivelin inhibited axonal damage and neuronal death in brain tissue, which was associated with elevated anti-apoptotic gene expression in ischemic neurons as well as increased axonal growth up until two-weeks post-stroke. Moreover, Colivelin activated STAT3 signaling, which may partially contribute to its beneficial effect against neuronal death and axon growth. In conclusion, Colivelin induce anti-apoptotic genes up-regulation, and activate JAK/STAT3 signaling after ischemic stroke, which may contribute to its effects of rescuing ischemic neuronal death and axonal remodeling. This study may justify further works to examine Colivelin as a single or adjunct therapy in ischemic stroke. © 2019 Elsevier Ltd

基金:
语种:
被引次数:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 医学
小类 | 3 区 神经科学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 神经科学
JCR分区:
出版当年[2017]版:
Q2 NEUROSCIENCES
最新[2023]版:
Q2 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [a]Shanxi Medical University, Taiyuan, China [e]Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China
通讯作者:
通讯机构: [a]Shanxi Medical University, Taiyuan, China [b]China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [c]Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China [d]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China [e]Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China [*1]Shanxi Medical University, Taiyuan, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17005 今日访问量:0 总访问量:906 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院